A patent at the University of Samarra on the treatment of breast cancer
Professor Dr. (Liqa’ Hussain Alwan) from the College of Education – Department of Chemistry obtained a joint patent with professor Ahmed Taha Yassin from the Baghdad Education Directorate Al-Karkh entitled (Using activated charcoal as a drug carrier for the treatment of breast cancer)
The study included the preparation of Nanocarbon as an adsorbent and drug carrier from a plant source, which is the stems of the Eucalyptus plant, and its diagnosis by various techniques, in addition to the preparation of Nanosilver from plant extracts and diagnosis by several methods, namely (FT-IR, SEM, BET, XRD, AFM, and TEM)…
Thermodynamic and Kinetic studied the adsorption of a mixture of Tamoxifen with Nanosilver, 0.000025 M of Tamoxifen, 0.000015 M of Nanosilver, and 0.4 g of Nanocarbon were used.
The results showed that adsorption is exothermic (ΔHo=-12.17) and occurs spontaneously (ΔGo=-) with a decrease in randomness (ΔSo=-).
The paper included a biochemical study of the possibility of using Nanocarbon as a carrier for the mixture of Tamoxifen with Nanosilver, in addition to improving the effectiveness of the drug under investigation in inhibiting cancer cells in the presence of the prepared nanomaterial, they applied to cancer-affected tissues obtained from Malaysia from:
Center For Natural Product Research: And Drug Discovery / Department Of Pharmacology / Faculty Of Medicine / University Of Malaya Kuala Lumpur / Malaysia.
This cancerous line was maintained, developed, and tested at the Biotechnology Research Center at Al-Nahrain University.
The results showed that the drug mixture and nanomaterials inhibited the growth of cancer cells by 41.2% for the (Drug/AgNPs) combination using a concentration of 200μg/ml, better than the inhibition of tamoxifen alone for cancer cells, which was 15.28% inhibition using the same concentration of 200μg/ml.
